A detailed history of Mc Lean Asset Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Mc Lean Asset Management Corp holds 1,926 shares of ABT stock, worth $220,006. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,926
Holding current value
$220,006
% of portfolio
0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$100.07 - $118.13 $192,734 - $227,518
1,926 New
1,926 $217 Million
Q1 2024

Apr 10, 2024

SELL
$109.52 - $120.96 $3,395 - $3,749
-31 Reduced 1.55%
1,973 $222 Million
Q4 2023

Jan 08, 2024

SELL
$90.19 - $110.4 $19,210 - $23,515
-213 Reduced 9.61%
2,004 $222 Million
Q3 2023

Oct 11, 2023

BUY
$95.53 - $114.62 $13,947 - $16,734
146 Added 7.05%
2,217 $216 Million
Q2 2023

Jul 10, 2023

SELL
$100.78 - $112.29 $4,131 - $4,603
-41 Reduced 1.94%
2,071 $226 Million
Q1 2023

Apr 11, 2023

SELL
$96.86 - $114.01 $26,539 - $31,238
-274 Reduced 11.48%
2,112 $214 Million
Q4 2022

Jan 19, 2023

BUY
$95.06 - $111.52 $13,118 - $15,389
138 Added 6.14%
2,386 $262 Million
Q3 2022

Oct 12, 2022

SELL
$96.76 - $112.03 $193 - $224
-2 Reduced 0.09%
2,248 $229,000
Q2 2022

Jul 07, 2022

BUY
$102.07 - $123.37 $1,531 - $1,850
15 Added 0.67%
2,250 $245,000
Q1 2022

Apr 08, 2022

SELL
$114.02 - $139.04 $25,768 - $31,423
-226 Reduced 9.18%
2,235 $265,000
Q4 2021

Jan 14, 2022

SELL
$115.53 - $141.46 $46,327 - $56,725
-401 Reduced 14.01%
2,461 $329,000
Q3 2021

Oct 27, 2021

BUY
$116.66 - $129.06 $6,649 - $7,356
57 Added 2.03%
2,862 $367,000
Q2 2021

Jul 19, 2021

SELL
$105.79 - $124.53 $5,077 - $5,977
-48 Reduced 1.68%
2,805 $330,000
Q1 2021

Apr 28, 2021

BUY
$108.84 - $128.23 $8,816 - $10,386
81 Added 2.92%
2,853 $347,000
Q4 2020

Jan 27, 2021

BUY
$105.0 - $114.42 $291,060 - $317,172
2,772 New
2,772 $304,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mc Lean Asset Management Corp Portfolio

Follow Mc Lean Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Lean Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mc Lean Asset Management Corp with notifications on news.